Karl Tryggvason,
Professor
Karl Tryggvason, MD, PhD, is Tanoto Professor of Diabetes Research at Duke-NUS and Professor of Medical Chemistry at Karolinska Institutet in Stockholm.
Tryggvason has published over 380 research articles. He is a member of the Swedish Royal Academy of Sciences, member of the Nobel Assembly and Board of Trustees of the Nobel Foundation, and he has received several international awards primarily for his kidney research, including the American Society of Nephrology Homer Smith Award and Louis Jeantet and Anders Jahre awards. Trygvasson is founder of four companies including NephroGenex, Inc. (USA) that develops a drug for diabetic kidney disease.
|
|
|
